Europe Minimally Invasive Surgery Devices Market Size (2024 - 2029)

Europe Minimally Invasive Devices Market Analysis

The Europe minimally-invasive surgery devices market is expected to register a CAGR of 7.7% over the forecast period.

The COVID-19 pandemic has had ramifications on various surgical procedures, including minimally invasive procedures. Due to the lockdown restrictions, a delay in diagnosis and treatments was observed in patients with various lifestyle-related and chronic diseases as a result of a reduction in hospital visits, which impacted the studied market. Patients were also avoiding visiting medical facilities that may be considered a potential source of infections, which also contributed to the delay in spinal surgeries, thereby impacting the minimally invasive devices in the region. In Europe, the rising cases of COVID-19 are expected to have a significant short-term negative impact on the medical aesthetics market. However, the adverse impacts of COVID-19 on the European economy can have significant indirect effects on the market. For instance, in February 2021, Central European authorities warned that they are witnessing increased COVID-19 infections across their region amid the discovery of new variants. However, the market showed significant traction within a few months, as the reduction in COVID-19 cases was reported due to the growing demand for minimally invasive surgical procedures in the region.

The major factors for the growth of the Europe minimally-invasive surgery devices market include the increasing prevalence of lifestyle-related and chronic disorders, technological advancements, and a higher acceptance rate of minimally-invasive surgeries over traditional surgeries.

Moreover, over the past decade, there has been a rise in the prevalence of several chronic diseases that need minimally invasive surgeries. Some of the major chronic diseases include cancer, kidney failure, and heart disease, among others, which are prevalent within the European region. For instance, as per the article published in Nature Reviews Cardiology in September 2021, cardiovascular disease (CVD) remained the most common cause of death in the European region. More than 60 million potential years of lives are lost to CVD in Europe annually. Similarly, as per GLOBOCAN data updated in 2020, there were 4.40 million new cancer cases in 2020, which is expected to increase and reach 5.53 million cases by 2040. Such an increase in the patient population is ultimately boosting the growth of surgeries within the region to avoid severe fatalities, thereby driving the demand for minimally invasive devices market over the forecast period.

Also, the European region witnessed a high proportion of the geriatric population. The population aged 65 and above is highly prone to various chronic diseases. For instance, according to the United Nations Population Fund's Statistics 2021, Italy has approximately 23.8% of the population aged 65 and above. Thus, the increasing aging population is prone to chronic diseases. As a result, these chronic diseases lead to a need for surgical procedures, which then lead to a surge in demand for minimally invasive devices driving the growth of the market over the forecast period.

Thus, due to the aforementioned reasons, the market is expected to show significant growth over the forecast period. However, the shortage of experienced professionals issues may slow down market growth.

Europe Minimally Invasive Devices Industry Segmentation

As per the scope of this report, minimally-invasive surgical devices refer to electrosurgical systems, robot-assisted surgical systems, and surgical equipment which are used during minimally-invasive surgical procedures. Europe's Minimally Invasive Surgery Devices Market is segmented by Product (Handheld Instruments, Guiding Devices, Electrosurgical Devices, Endoscopic Devices, Laparoscopic Devices, Monitoring and Visualization Devices, Ablation Devices, Laser-based Devices, Robotic-assisted Surgical Systems, and Other MIS Devices), Application (Aesthetic, Cardiovascular, Gastrointestinal, Gynecological, Orthopedic, Urological, and Other Applications), and Geography (Germany, United Kingdom, France, Italy, Spain, and Rest of Europe). The report offers the value (in USD million) for all the above segments.